Tanya Lalani
Family · New Orleans, LANPI 1477001188
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,657 of the $5,688 with a category attached, or 81.9%. It is spread thinly across 33 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $58.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Karyopharm Therapeutics Inc.$923
- W. L. Gore & Associates, Inc.$899
- Bristol Myers Squibb$408
- Johnson & Johnson$398
- Incyte Corporation$393
- Astellas Pharma US Inc$272
- plus $2K from 27 others
What the payments were for
- Consulting fees$72013%
- Food & beverage$4,65782%
- Education$3115%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Karyopharm Therapeutics Inc. | 6 | $923 |
| W. L. Gore & Associates, Inc. | 7 | $899 |
| Bristol Myers Squibb | 10 | $408 |
| Johnson & Johnson | 7 | $398 |
| Incyte Corporation | 6 | $393 |
| Astellas Pharma US Inc | 7 | $272 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $242 |
| Rigel Pharmaceuticals, Inc. | 2 | $239 |
| Servier Pharmaceuticals LLC | 2 | $235 |
| Janssen Scientific Affairs, LLC | 5 | $222 |
| Atricure, Inc. | 1 | $179 |
| AbbVie | 6 | $144 |
| Secura Bio, Inc. | 1 | $143 |
| Genentech USA, Inc. | 6 | $127 |
| Jazz Pharmaceuticals Inc. | 2 | $119 |
| E.r. Squibb & Sons, L.L.C. | 1 | $110 |
| Gilead | 1 | $97 |
| Sanofi-aventis U.S. LLC | 3 | $84 |
| Merck | 3 | $70 |
| Legend Biotech USA Inc. | 2 | $55 |
| Stemline Therapeutics Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| AstraZeneca | 1 | $27 |
| Tersera Therapeutics LLC | 1 | $27 |
| UCB, Inc. | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Seagen Inc. | 1 | $21 |
| Novartis | 1 | $18 |
| Argenx US, Inc. | 1 | $16 |
| Sanofi US Services Inc. | 1 | $13 |
| Sanofi | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XPOVIO$840
- GORE VIABAHN VBX Balloon Expandable Endo$734
- JAKAFI$356
- IMBRUVICA$247
- Tavalisse$239
- Rezlidhia$239
- GAVRETO$239
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$179
- Copiktra$143
- Reblozyl$131
- GORE PROPATEN Vascular Graft$129
- TIBSOVO$125
- TECVAYLI$122
- CARVYKTI$122
- DARZALEX$122
- TALVEY$122
- CRESEMBA$112
- VYXEOS$102
How this compares
$5,688 in reported general payments places this provider in the 90th percentile of 3,610 family providers in Louisiana.
Other family in New Orleans
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Amy SchmittNew Orleans$48K
- Eric BabineauxNew Orleans$32K
- Cherie AlbroNew Orleans$29K
- Aimee ScroggsNew Orleans$20K
- Kelly BaquetNew Orleans$18K
- Lori LemoineNew Orleans$17K
- Jennifer GreenheckNew Orleans$15K
- Joseph DefraitesNew Orleans$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.